Literature DB >> 21207082

Hepatitis B virus regulates Raf1 expression in HepG2.2.15 cells by enhancing its promoter activity.

Yuanyuan Tian1, Yuan Hu, Zengchan Wang, Ke Chen, Lei Zhang, Liying Wang, Min Ren, Ailong Huang, Hua Tang.   

Abstract

Raf1 kinase is a central component of many signaling pathways that are involved in normal cell growth and oncogenic transformation. The expression of Raf1 is significantly increased in hepatocellular carcinoma (HCC). HBV is a major risk factor for HCC. HBx protein can increase the expression of Raf1; however, the mechanism of how HBV regulates Raf1 expression is still unknown. In this study, we showed the Raf1 expression was significantly higher in HepG2.2.15 cells than that in HepG2 cells in vitro. HBV could up-regulate Raf1 expression by enhancing the activity of its promoter in a dose-dependent manner, and HBs and HBx may be involved in this process. After silencing HBs and HBx by using RNA interference, the expression of Raf1 in HepG2.2.15 cells could be significantly inhibited. These results might provide useful information for understanding the mechanism of HCC induced by HBV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207082     DOI: 10.1007/s00705-010-0901-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

1.  Long noncoding RNA UCA1 promotes the proliferation of hypoxic human pulmonary artery smooth muscle cells.

Authors:  Tian-Tian Zhu; Rui-Li Sun; Ya-Ling Yin; Jin-Ping Quan; Ping Song; Jian Xu; Ming-Xiang Zhang; Peng Li
Journal:  Pflugers Arch       Date:  2018-10-23       Impact factor: 3.657

2.  Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells.

Authors:  Kai Li; Shijia Ding; Ke Chen; Dongdong Qin; Jialin Qu; Sen Wang; Yanrui Sheng; Chengcheng Zou; Limin Chen; Hua Tang
Journal:  Hepat Mon       Date:  2013-05-27       Impact factor: 0.660

3.  Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Authors:  Yiyi Cao; Juan Chen; Dan Wang; Hong Peng; Xixi Tan; Dongmei Xiong; Ailong Huang; Hua Tang
Journal:  Oncotarget       Date:  2015-11-10

4.  RAF1 Expression is Correlated with HAF, a Parameter of Liver Computed Tomographic Perfusion, and may Predict the Early Therapeutic Response to Sorafenib in Advanced Hepatocellular Carcinoma Patients.

Authors:  Ninzi Tian; Dong Wu; Ming Tang; Huichuan Sun; Yuan Ji; Cheng Huang; Lingli Chen; Gang Chen; Mengsu Zeng
Journal:  Open Med (Wars)       Date:  2020-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.